Research Interests:
- Hepato-pancreaticobiliary malignancies
- Peritoneal surface malignancies
- Sarcoma
- Melanoma
Biography
I am one of the complex general surgical oncology fellows at Roswell Park Comprehensive Cancer Center. I obtained my BA in Biology and Economics from Bryn Mawr College and my MD from Northeast Ohio Medical University. I completed surgical residency at Penn State in Hershey, PA and completed a two-year research fellowship obtaining my Master's in Clinical Research from Penn State College of Medicine. My clinical and academic interests include tumors of the liver, bile ducts, and pancreas, peritoneal surface malignancies, melanomas, and sarcomas with a focus on clinical outcomes research using national and institutional databases.
Positions
Roswell Park Comprehensive Cancer Center
- Surgical Oncology Fellow
-
Department of Surgical Oncology
Background
Education and Training
- 2013-2017 - MD - Northeast Ohio Medical University, Rootstown, OH
- 2008-2012 - MScR - Penn State College of Medicine, Hershey, PA
Residency
- 2017-2024 - General Surgery, Penn State Medical Center, Hershey, PA
Fellowship
- 2024-2026 - Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
Board Certification
- American Board of Surgery - General Surgery
Honors & Awards
- Alpha Omega Alpha
- Mark J. Young Award for Outstanding Scholarship in Public Health Sciences
Publications
Olecki EJ, Swinarska J, Perez Holguin RA, Stahl KA, Wong WG, Peng JS, Dixon MEB. Is preoperative biliary stenting associated with increased rate of postoperative complications for patients undergoing pancreatoduodenectomy? A review of national surgical quality improvement program data. HPB (Oxford). 2022 Sep;24(9):1501-1510. doi: 10.1016/j.hpb.2022.01.006. Epub 2022 Jan 24. PMID: 35135722.
Olecki EJ, Stahl KA, Torres MB, Peng JS, Shen C, Dixon MEB, Gusani NJ. Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival. J Surg Oncol. 2021 Jul;124(1):79-87. doi: 10.1002/jso.26481. Epub 2021 Apr 9. PMID: 33836095.
Olecki EJ, Stahl KA, Torres MB, Peng JS, Dixon M, Shen C, Gusani NJ. Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology. Ann Surg Oncol. 2021 Jun;28(6):3111-3122. doi: 10.1245/s10434-020-09546-8. Epub 2021 Jan 31. PMID: 33521899.
Olecki EJ, Stahl K, Peng JS, Dixon M, Gusani NJ, Shen C. Undertreatment of Pancreatic Cancer: Role of Surgical Pathology. Ann Surg Oncol. 2021 Mar;28(3):1581-1592. doi: 10.1245/s10434-020-09043-y. Epub 2020 Aug 26. PMID: 32851518.